RFA-AI-25-035: Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2025.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 7, 2025.
From the official notice on Grants.gov, last changed September 10, 2025. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP01
- Clinical trialsOptional
- Funded byNIAID
- Median yearly award$630,634
- Typical project length5 years
- P01, Research Program Project Grant. Several related research projects around one theme, with shared core facilities. Other open P01 notices.
Projects funded under RFA-AI-25-035 were run by National Institute of Allergy and Infectious Diseases (NIAID, 4 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-AI-25-035 in the NIH Guide.
Key dates
| Posted | September 2, 2025 |
|---|---|
| Deadline | November 7, 2025 |
| Archived by Grants.gov | December 13, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Is this a realistic fit?
- Most of the program's money (67% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity (NOFO) is to support basic research to understand the fundamental mechanisms underlying human-to-human transmission of seasonal influenza virus. The NOFO will establish an Influenza Transmission Research Consortium comprised of a network of individual Influenza Transmission Research Centers. Centers should propose collaborative, multidisciplinary teams that will investigate the dynamics and drivers of influenza transmission and develop novel resources to further the field of respiratory virus transmission.
Funded under RFA-AI-25-035 so far
NIH funded 4 projects under RFA-AI-25-035 in fiscal 2026, at 4 institutions. The median yearly award was $630,634.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| The Duke Catalyzing Observations into Mechanistic Models of Influenza Transmission (COMMIT) Center | Duke University | 2026 | $3.6 million |
| Connecting respiratory virus dynamics, coinfections, and symptoms to risk of real-world influenza transmission events | University of Michigan at Ann Arbor | 2026 | $749,112 |
| Administrative Core | St. Jude Children's Research Hospital | 2026 | $408,334 |
| Administrative Core | University of Missouri-Columbia | 2026 | $384,982 |
Who has won Allergy and Infectious Diseases Research grants before
From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Washington | 85 | $938 million |
| Duke University | North Carolina | 230 | $781 million |
| University of California, Los Angeles | California | 138 | $745 million |
| The Johns Hopkins University | Maryland | 321 | $668 million |
| Emory University | Georgia | 282 | $650 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-AI-25-035 still open?
No. It closed on November 7, 2025.
Who can apply for Influenza Transmission Research Consortium (P01 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Influenza Transmission Research Consortium (P01 Clinical Trial Optional)?
Closed November 7, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-AI-25-035?
NIH RePORTER lists 4 projects funded under RFA-AI-25-035 in fiscal 2026, at 4 institutions. The most were at Duke University, University of Michigan at Ann Arbor, St. Jude Children's Research Hospital.
Who has won Allergy and Infectious Diseases Research grants before?
The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.
Similar open grants
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
- NIH Research Program Projects (Parent P01 Clinical Trial Optional)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)